Pharmacogenomics Technology Market Size, Share & Trends Analysis growing at a CAGR of 8.1% from 2025 to 2030
The global pharmacogenomics technology market size was estimated at USD 7,633.2 million in 2024 and is projected to reach USD 12,380.1 million by 2030, growing at a CAGR of 8.1% from 2025 to 2030. Advancements in genomics have led to an increased understanding of genetic variations and their impact on drug response, which is a primary driving factor in the growth of the market for pharmacogenomics technology.
Key Market Trends & Insights
- In terms of region, North America was the largest revenue generating market in 2024.
- Country-wise, Kuwait is expected to register the highest CAGR from 2025 to 2030.
- In terms of segment, oncology accounted for a revenue of USD 3,357.6 million in 2024.
- Cardiovascular Disease is the most lucrative therapeutics area segment registering the fastest growth during the forecast period.
Market Size & Forecast
- 2024 Market Size: USD 7,633.2 Million
- 2030 Projected Market Size: USD 12,380.1 Million
- CAGR (2025-2030): 8.1%
- North America: Largest market in 2024
Request a free sample copy or view report summary: https://www.grandviewresearch.com/industry-analysis/pharmacogenomics-technology-market/request/rs1
The rising prevalence of chronic disease has led to an increased demand for personalized medicine, which is contributing to market growth. According to a World Health Organization (WHO) report published in May 2023, chronic diseases such as cardiovascular diseases, diabetes, cancer, and respiratory illnesses are expected to cause 86% of all deaths globally, representing a 90% increase since 2019. Furthermore, the reduction in the cost of genomic sequencing and technological advancements is aiding market growth.
Advancements in genomics have greatly improved the understanding of how genes affect health. Next-generation sequencing technologies have made analyzing DNA and RNA sequencing faster, which has led to the analysis of large amounts of genetic information. Genome-wide association studies have led to the identification of specific gene variations linked to various illnesses, therefore providing insights into the genetic causes of diseases. In May 2024, Qiagen launched the QIAseq Multimodal DNA/RNA Library Kit. This kit facilitates multiomic studies by enabling the simultaneous preparation of DNA and RNA libraries from a single sample, advancing precision medicine research.
